Star Scientific, Inc., together with its subsidiaries, engages in the development, implementation, and licensing of tobacco curing technology that prevents the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the tobacco-specific nitrosamines (TSNA). It also involves in the manufacture, sale, marketing, and development of very low-TSNA dissolvable smokeless tobacco products, including ARIVA compressed powdered tobacco, cigalett pieces, STONEWALL Hard Snuff, and risk tobacco products. In addition, the company develops pharmaceutical products that have a botanical, tobacco-based component designed to treat tobacco dependence and a range of neurological conditions, including Alzheimers disease, Parkinsons disease, schizophrenia, and depression. Further, Star Scientific engages in the development of non-nicotine nutraceutical products designed to assist individuals who have ceased using tobacco or who are in the process of stopping tobacco, as well as related non-nicotine products that would be helpful to consumers in maintaining a healthy metabolism. It sells its smokeless tobacco products through tobacco distributors and wholesalers in the United States. The company was founded in 2000 and is based in Glen Allen, Virginia.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for CIGX